Hyoscine (Butylbromide)
Also known as: Butylscopalamine bromide
Hyoscine (Butylbromide) used as an antispasmodic agent. Hyoscine (Butylbromide) also used as an antiemetic for travel sickness.
Primary Characteristics
Hyoscine (Butylbromide) is also known as Butylscopalamine bromide, Hyoscine .
It is of Natural origin and belongs to Tropane Alkaloid.
It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action. It is also classified under Gastrointestinal Anticholinergics/Antispasmodics .
Molecular Weight: 440.4 · pKa: 8.1 · Solubility in Water: 1 in 1 · Solubility in Alcohol: 1 in 50 · Non-proprietary name: Hyoscine (Butylbromide).

Pharmacokinetics
Absorption: Hyoscine (Butylbromide) has an oral bioavailability is 9% (±1%).
Distribution: Hyoscine (Butylbromide) has a plasma protein binding is 10%.
Elimination: it is metabolised via hepatic, plasma half-life is 8 hr, renal excretion is >2%.
Advertisement
Indications
Hyoscine (Butylbromide) is primarily indicated in conditions like Acute spasm and spasm in diagnostic procedures, Aspiration prophylaxis, Bradycardia, Cycloplegia induction, Drying secretions, amnesia, Iritis, Irritable bowel syndrome, Motion sickness, Mydriasis induction, Reduction of excessive respiratory secretions (death rattle) in palliative care, Smooth muscle spasm, Symptomatic relief of GI-disorders, The pain of bowel colic in palliative care, Uveitis.
Hyoscine (Butylbromide) is also indicated for secondary conditions like Premedication in anaesthesia.
Contraindications
Hyoscine (Butylbromide) is contraindicated in conditions like Glucoma, Prostatic hypertrophy, Paralytic ileus.
Dosage
Hyoscine (Butylbromide)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 20 mg | 20 mg | Every 4h | PO | In Anti spasmodic condition |
| 20 mg | 20 mg | — | Slow IV | 20 mg repeated after 30 min 100 mg daily |
| Paediatric Dosage (20kg) | ||||
| 15 ug/kg | 15 ug/kg | — | Intra Muscular | Single Dose |
| 15 ug/kg | 15 ug/kg | — | Subcutaneous | Single Dose |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Hyoscine (Butylbromide) produces potentially life-threatening effects which include Seizures , Transient arrhythmias, Hallucination. Careful monitoring is needed with proper medical management.
The signs and symptoms that are produced after acute overdosage of Hyoscine (Butylbromide) are Coma, Blurred vision, Hallucinations , Dry flushed skin, Delirium, Ataxia, Restlessness , Rapid & irregular pulse, Decreased salivary secretions, Increased heart rate, Loss of accomodation, Flushed skin, scarlet, weak pulse, Excitement.
Hyoscine (Butylbromide) is known to cause more or less tolerable side effects which are usually transient. These include Blurring of vision, Constipation , Cycloplegia, Delirium , Dizziness, Drowsiness, Dry mouth, Fatigue, Headache, Loss of accomodation, Mydriasis, Nausea and vomiting, Palpitation, Restlessness, Swallowing difficulties, Tachycardia, Thirst, Transient bradycardia, Urinary RetentionX.
Warnings / Precautions
Available Brands
Storage Conditions
Drug Classification
- 1.17.5 — Antispasmodics
Manufacturers
Manufacturers of Hyoscine (Butylbromide) in Pakistan: